Ascendis Pharma Stock (NASDAQ: ASND) stock price, news, charts, stock research, profile.
Open | $145.98 |
Close | - |
Volume / Avg. | 59.91K / 569.77K |
Day Range | $143.98 - $146.76 |
52 Wk Range | 85.29 - 161.00 |
Market Cap | $8.56B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 60 |
Short Interest | 8.39% |
Days to Cover | 11.18 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ascendis Pharma (NASDAQ:ASND) through any online brokerage.
Other companies in Ascendis Pharma’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).
Ascendis Pharma has a consensus price target of $179.11.
The stock price for Ascendis Pharma (NASDAQ: ASND) is $144.195 last updated September 24, 2024 at 11:04 AM EDT.
There are no upcoming dividends for Ascendis Pharma.
Ascendis Pharma’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Ascendis Pharma.
Ascendis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.